Back to Search
Start Over
Abrocitinib highly effective as long-term monotherapy in AD
- Source :
- Dermatology News. December, 2020, Vol. 51 Issue 12, p11, 1 p.
- Publication Year :
- 2020
-
Abstract
- FROM THE EADV CONGRESS About 70% of patients on the oral selective Janus kinase 1 inhibitor abrocitinib for moderate to severe atopic dermatitis (AD) achieved high-efficacy responses without need for [...]
- Subjects :
- Atopic dermatitis
Health
Health care industry
Subjects
Details
- Language :
- English
- ISSN :
- 23767006
- Volume :
- 51
- Issue :
- 12
- Database :
- Gale General OneFile
- Journal :
- Dermatology News
- Publication Type :
- Periodical
- Accession number :
- edsgcl.645639036